Spanish version of modified Story Memory Technique effective for Mexicans with MS

A team of researchers reported preliminary findings for efficacy of the Spanish version of the modified Story Memory Technique, a cognitive intervention developed at Kessler Foundation (KF-mSMT™). Their study, conducted in Mexicans with multiple sclerosis, is an important step toward addressing the void in evidence-based rehabilitative interventions for treating the cognitive effects of multiple sclerosis across diverse cultural populations. The article, "Efficacy of the Spanish modified Story Memory Technique in Mexicans with multiple sclerosis: A pilot randomized controlled trial," (doi: 10.3233/NRE-192808) was epublished on November 28, 2019 by NeuroRehabilitation.

The authors are Denise Krch, PhD, Anthony Lequerica, PhD, and Nancy Chiaravalloti, PhD, of Kessler Foundation, Adriana Aguayo Arelis, MSc, and Brenda V. Rabago Barajas, MS, of Universidad Enrique D´ıaz de Leon and the Mexican MS Foundation, Guadalajara, Mexico, and Juan Carlos Arango-Lasprilla, MD, of Cruces University Hospital, Bizkaia, Spain, Basque Foundation for Science, Bilbao, Spain, and University of the Basque Country, Leoia, Spain.

Link to article: DOI: https://content.iospress.com/articles/neurorehabilitation/nre192808

While problems with learning and memory occur across populations with multiple sclerosis around the world, the availability of evidence-based cognitive interventions in different languages is limited. The lack of interventions in Spanish presents a barrier to the rehabilitation of many individuals in the Hispanic community who have cognitive deficits caused by multiple sclerosis. An international team of researchers has adapted the English language KF-mSMT into Spanish, for use in the cognitive rehabilitation of Mexicans with multiple sclerosis.    

In this pilot study, 20 participants with multiple sclerosis, relapsing-remitting type, were randomized to either treatment (n = 10) or placebo control (n = 10) groups. The treatment group received the Spanish adaptation of the KF-mSMT, a 10-session intervention that teaches imagery and context to facilitate learning. The control group participated in 10 sessions based on similar content and presentation. All participants underwent baseline and follow-up neuropsychological assessments. Individuals in the treatment group showed significant improvements in learning and life satisfaction relative to the control group, suggesting that that this adaptation of the KF-mSMT may be an effective rehabilitative tool in Spanish-speaking populations with MS, according to Dr. Krch, senior research scientist in the Center for Traumatic Brain Injury Research.

This is an example of how cultural adaptation can be an effective way to extend evidence-based interventions to non-English speaking populations. The positive outcomes seen in this pilot study of urban-based Mexicans have important implications. While further testing is needed, we anticipate that this adaptation of the modified Story Memory Technique will be applicable to the diverse Spanish-speaking population in the U.S., in addition to those with Mexican heritage.”

Dr. Denise Krch, senior research scientist in the Center for Traumatic Brain Injury Research

Kessler Foundation researchers have documented the efficacy of this tool in the U.S. for English-speaking populations with traumatic brain injury as well as multiple sclerosis. “Based on our prior research,” noted Dr. Krch, “the modified Story Memory Technique may also prove useful in the rehabilitation of Spanish-speakers with cognitive deficits caused by traumatic brain injury.”  

The KF-mSMT is available from Kessler Foundation in English and Spanish for use by rehabilitation professionals.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mitochondrial genetics shed light on ALS Risk and protection